The Ministry of Health in Fiji is committed to addressing the recent global shortage of intravenous (IV) fluids that has raised concerns across over 200 healthcare facilities in the country. The shortage is anticipated to persist until 2025, but the Ministry has reassured the public that IV fluids are not out of stock domestically.
Recently, the Fiji Pharmaceutical & Biomedical Services (FPBS) has received an initial shipment of 3,000 units of saline solution, with an additional 4,200 units awaiting clearance from the Fiji Procurement Office. The Ministry remains optimistic that these supplies will be adequate to handle the surge in Dengue Fever cases currently affecting the population.
The Ministry of Health has also encouraged the public to actively participate in maintaining their health by cleaning their surroundings. This is considered one of the primary methods to prevent the spread of Dengue Fever.
Additionally, in response to concerns raised earlier regarding various medication shortages reported throughout Fiji’s healthcare system, the Ministry has confirmed that HIV medications are currently well-stocked and available.
This proactive approach and the ongoing supply chain management efforts by the Health Ministry indicate a focus on both immediate needs and long-term solutions to enhance the resilience of Fiji’s healthcare system. Experts have noted this situation as a potential opportunity for significant reforms within the healthcare supply chain, which could lead to improved health outcomes for the population in the future. They highlight that addressing these procurement challenges can ultimately strengthen access to essential medicines and services for all citizens.
With a collaborative effort underway among healthcare stakeholders, there is a sense of optimism about bolstering the healthcare infrastructure, enabling better responsiveness to patient needs, and improving the overall healthcare delivery in Fiji.
Leave a comment